59
Views
5
CrossRef citations to date
0
Altmetric
Case Series

Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification

, , &
Pages 925-931 | Published online: 18 Jun 2012

References

  • ChuangLHYeungLWangNKChenHSKuWCLaiCCSecondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusionJ Ocul Pharmacol Ther201026432532820653482
  • Vasconcelos-SantosDVNehemyPGSchachatAPNehemyMBSecondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factorsRetina200828457358018398360
  • YoungSLarkinGBranleyMLightmanSSafety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitisClin Experiment Ophthalmol20012912611272779
  • WingateRJBBeaumontPEIntravitreal triamcinolone and elevated intraocular pressureAust NZJ Ophthalmol1999276431432
  • ChinHParkTMoonYOhJDifference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyesRetina200525555656016077349
  • SchindlerRHChandlerDThresherRMachemerRThe clearance of intravitreal triamcinolone acetonideAm J Ophthalmol19829344154177072807
  • ChangSLXII Edward Jackson lecture: open angle glaucoma after vitrectomyAm J Ophthalmol200614161033104316765671
  • KoreenLYoshidaNEscariaoPIncidence of, risk factors for, and combined mechanism of late-onset open-angle glaucoma after vitrectomyRetina201132116016721765372
  • BlankenshipGWFlynnHWJrKokameGTPosterior chamber intraocular lens insertion during pars plana lensectomy and vitrectomy for complications of proliferative diabetic retinopathyAm J Ophthalmol19891081152750829
  • JunZPavlovicSJacobiKWResults of combined vitreoretinal surgery and phacoemulsification with intraocular lens implantationClin Experiment Ophthalmol200129530731111720157
  • SoheilianMMirdehqhanSAPeymanGASutureless combined 25-gauge vitrectomy, phacoemulsification, and posterior chamber intraocular lens implantation for management of uveitic cataract associated with posterior segment diseaseRetina200828794194618698295
  • LeeDYJeongHSSohnHJNamDHCombined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathyRetina20113191753175821555968
  • HikichiTKosakaSTakamiK23- and 20-gauge vitrectomy with air tamponade with combined phacoemulsification for idiopathic macular hole: a single-surgeon studyAm J Ophthalmol2011152111412121529764
  • EnaidaHHataYUenoAPossible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseasesRetina200323676477014707824
  • BhisitkulRBWinnBJLeeOTNeuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhageInvest Ophthalmol Vis Sci20084994071407718421081
  • EbrahemQMinamotoAHoppeGAnand-ApteBSearsJETriamcinolone acetonide inhibits IL-6 and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptorsInvest Ophthalmol Vis Sci200647114935494117065510
  • The SCORE Study Research GroupA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5Arch Ophthalmol200912791101111419752419
  • InoueMTakedaKMoritaKYamadaMTanigawaraYOguchiYVitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injectionAm J Ophthalmol200413861046104815629301
  • KonstantinidisLGerguigaMBeknazarEWolfensbergerTJAnatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membraneRetina20092981119112719734764
  • MoshfeghiAANugentAKNomotoHSanisloSRKitchensJWMoshfeghiDMTriamcinolone acetonide preparations: impact of crystal size on in vitro behaviorRetina200929568969819373129
  • SpitzerMSMlynczakTSchultheissMPreservative-free triamcinolone acetonide injectable suspension versus “traditional” triamcinolone preparations: impact of aggregate size on retinal biocompatibilityRetina201131102050205721747324